Note: We are no longer accepting Benicar cases.
Benicar is Used to Treat Hypertension
Manufactured by Daiichi Sankyo, Benicar (olmesartan medoxomil) is used to treat Hypertension (high blood pressure). Benicar belongs to a class of drugs known as angiotensin II receptor blockers (ARBs). ARBs help to lower high blood pressure by blocking the effect of the substance Angiotensin II, which can narrow blood vessels. The blocking of this substance allows the blood vessels to widen which makes it easier for the heart to pump blood throughout the body. While Benicar has been touted as safer and more effective than other ARBs it is the only ARB that has been linked with to a chronic health condition known as sprue-like enteropathy.
Benicar Usage Comes With Serious Risks
Roughly ten years after it Benicar hit the market a study linking the medication to a severe form of sprue-like enteropathy was published in Mayo Clinic Proceedings in 2012. Sprue-like enteropathy is an intestinal issue which causes its victims to suffer from symptoms such as severe chronic diarrhea, nausea, vomiting, weight loss and other intestinal issues.
Its symptomology is similar to Celiac disease (a gluten allergy) and the victims of sprue-like enteropathy are often misdiagnosed with Celiac disease and given the wrong treatment. In July of 2013, following the Mayo Clinic study, the FDA issued a warning about the risk of sprue-like enteropathy associated with olmesartan use and approved a label change to include a warning of such side effects.
In addition to the risk of sprue-like enteropathy, the use of Benicar could also lead to the development of villous atrophy. Villous atrophy is a condition that affects the lining of the intestines and hinders the body’s ability to absorb nutrients. The condition may come about from the chronic diarrhea that occurs with sprue-like enteropathy and may cause additional problems such as dehydration and malnourishment.
The victims of these conditions have turned to the courts in order to seek compensation for the injuries they have sustained.
Lawsuits against the Makers of Benicar
The FDA warning alerted people to the fact that their injuries may have been related to their Benicar use. In February of 2014 some of the first lawsuits were filed against Daiichi Sankyo in New Jersey State Court. Since the initial filings, the number of lawsuits being filed continues to grow. The basis of these suits is that Daiichi Sankyo failed to properly warn about the risk of severe sprue-like enteropathy associated with Benicar.
The number of cases filed in federal court has become so numerous that in April of 2015 the U.S. Judicial Panel on Multidistrict Litigation consolidated all Benicar sprue-like enteropathy cases pending in federal court into one Federal Multidistrict Litigation (MDL) in the District of New Jersey. The number of cases being filed is expected to continue to grow.
Do I have a case?
Do I have a case?
Sanders Phillips Grossman is currently reviewing cases for those who have taken Benicar and suffered severe gastrointestinal side effects. If you or a loved one have taken Benicar and suffered from one of the following:
- Chronic and severe diarrhea
- Nausea and vomiting
- Substantial weight loss
- Other gastrointestinal issues
About Sanders Phillips Grossman
Sanders Phillips Grossman has been holding pharmaceutical companies responsible for injuring individuals by their defective drugs and devices for over 30 years. Defective drugs are pharmaceuticals with side effects that potentially harm, injure, or kill the patient to the point that they outweigh the drug’s intended benefits. Defective devices, such as faulty prosthetics, implants, pacemakers or surgical instruments can harm patients when the product is defective in the manufacturing process, design or marketing strategy.
Pharmaceutical companies are some of the largest, wealthiest, and most influential corporate entities in the world. Sanders Phillips Grossman and its predecessors have recovered over one billion dollars for injured consumers. Our firm’s history in dealing with drug and medical device injury claims has allowed us to take leadership roles in many of the national defective drug and device litigations.
Nationally recognized as a leading plaintiff’s law firm, we handle cases in all 50 states and Puerto Rico.
Read more about our attorneys here.